Of the >480,000 probes on the methylation chip, we discarded probes with ≥90 % sequence similarity to multiple genomic locations, with sequence variants in the probe binding region (1000 Genomes Project, SNPs with a minor allele frequency ≥2/120), and probes located on sex chromosomes, leaving 392,904 autosomal probes for further analysis.
In our testing, VARiD performs more accurately than AB's Corona Lite pipeline for just color-space data, while its ability to incorporate letter-space data allows for more accurate determination of genomic variants using multiple read types, simultaneously.
However, we cannot exclude the possibility that these miRNA variants originate from multiple genomic loci.
As an alternative to large-scale variant validation studies, we developed the Recalibration and Interrelation of genomic sequence data with the GATK (RIG) workflow to integrate information from multiple genomic sources and identify reliable sets of variants.
Of these 47 SNPs remaining we then excluded those failing Sequenom genotyping algorithms (excludes SNPs which are in highly homologous regions, have multiple genomic targets, or are close to other variants which may confound the genotyping).
To mimic complicated genomic variants in human diseases, such as multiple gene deletions or mutations, two or more small guide RNAs (sgRNAs) need to be introduced all together.
Genomic variants are associated to phenotypic descriptions captured at multiple levels.
For example, the impact of copy number variation and other genomic variants on the expressed transcriptome is an area that requires simultaneous comparison of multiple data sets.
Furthermore, there have been significant technological advances in measuring genomic variants, proteins and peptides, and small molecule metabolites that include next-generation genomic sequencing, immuno-multiple reaction monitoring mass spectrometry, flow cytometry, and protein microarrays [ 41– 41].
